What does Avandia look like?
Note: Multiple pictures are displayed for those medicines available in different strengths, marketed under different brand names and for medicines manufactured by different pharmaceutical companies. Multi ingredient medications may also be listed when applicable.
All images for "Avandia"
![Avandia (Rosiglitazone [ row-zi-gli-ta-zone ])-GSK 4-4 mg-Orange-Five-sided](https://cdn.themeditary.com/vimedia/h200/2023/07/13/avandia-rosiglitazone-gsk-4-4-mg-orange-five-sided-9412841-6549.webp "Avandia (Rosiglitazone [ row-zi-gli-ta-zone ])-GSK 4-4 mg-Orange-Five-sided")
| GSK 4 Pill - orange five-sided | |
| Drug: | Avandia |
| Strength: | 4 mg |
| Imprint: | GSK 4 |
| Color: | Orange |
| Shape: | Five-sided |
| View details | |
![Avandia (Rosiglitazone [ row-zi-gli-ta-zone ])-SB 8-8 mg-Brown-Five-sided](https://cdn.themeditary.com/vimedia/h200/2023/07/13/avandia-rosiglitazone-sb-8-8-mg-brown-five-sided-9412401-5606.webp "Avandia (Rosiglitazone [ row-zi-gli-ta-zone ])-SB 8-8 mg-Brown-Five-sided")
| SB 8 Pill - brown five-sided, 12mm | |
| Drug: | Avandia |
| Strength: | 8 mg |
| Imprint: | SB 8 |
| Color: | Brown |
| Shape: | Five-sided |
| View details | |
![Avandia (Rosiglitazone [ row-zi-gli-ta-zone ])-SB 4-4 mg-Orange-Five-sided](https://cdn.themeditary.com/vimedia/h200/2023/07/13/avandia-rosiglitazone-sb-4-4-mg-orange-five-sided-9411976-4631.webp "Avandia (Rosiglitazone [ row-zi-gli-ta-zone ])-SB 4-4 mg-Orange-Five-sided")
| SB 4 Pill - orange five-sided, 10mm | |
| Drug: | Avandia |
| Strength: | 4 mg |
| Imprint: | SB 4 |
| Color: | Orange |
| Shape: | Five-sided |
| View details | |
![Avandia (Rosiglitazone [ row-zi-gli-ta-zone ])-SB 2-2 mg-Pink-Five-sided](https://cdn.themeditary.com/vimedia/h200/2023/07/13/avandia-rosiglitazone-sb-2-2-mg-pink-five-sided-9411975-4627.webp "Avandia (Rosiglitazone [ row-zi-gli-ta-zone ])-SB 2-2 mg-Pink-Five-sided")
| SB 2 Pill - pink five-sided, 10mm | |
| Drug: | Avandia |
| Strength: | 2 mg |
| Imprint: | SB 2 |
| Color: | Pink |
| Shape: | Five-sided |
| View details | |
